## Abstract Rabbit hemolysate‐loaded microcapsules having sulfonic acid groups on their surface were prepared and rabbit platelet adhesion onto the sulfonated surface was examined kinetically. Rabbit platelets adhered more markedly onto the surface of a higher charge density than that of a lower on
Polypeptide multilayer nanofilm artificial red blood cells
✍ Scribed by Naveen Palath; Sujaykumar Bhad; Reza Montazeri; Christopher A. Guidry; Donald T. Haynie
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 465 KB
- Volume
- 81B
- Category
- Article
- ISSN
- 1552-4973
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Reliable encapsulation of hemoglobin (Hb) within polypeptide multilayer nanofilms has been achieved by a template‐based approach, and protein functionality has been demonstrated postencapsulation. The method is general in scope and could be useful for many other encapsulants. Met‐Hb was adsorbed onto 5 μm‐diameter CaCO~3~ microparticles, and the Hb‐coated particles were encapsulated within a multilayer nanofilm of poly(L‐glutamic acid) (PLGA) and poly(L‐lysine) (PLL) by layer‐by‐layer assembly. The CaCO~3~ templates were then dissolved within the PLGA/PLL nanofilms by addition of ethylenediaminetetraacetic acid. Encapsulation of Hb was proved by fluorescence microscopy, the pH‐dependence of retention of Hb was determined by visible wavelength absorbance, and conversion of the encapsulated met‐Hb to deoxy‐Hb and oxy‐Hb was demonstrated by spectroscopic analysis of the Soret absorption peak under various conditions. It thus has been shown that control of Hb oxygenation within polypeptide multilayer nanofilm artificial cells is possible, and that Hb thus encapsulated can bind, release, and subsequently rebind molecular oxygen. This work therefore represents an advance in the development of polypeptide multilayer film artificial red blood cells. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2006
📜 SIMILAR VOLUMES
## Abstract In routine clinical procedures, blood transfusion is now suffering from the defects of the blood products, like cross‐matching, short storage time and virus infection. Various blood substitutes have been designed by researchers through continual efforts. With recent progress in nanotech